The cannabinoid receptor type two is a therapeutic target for muscular dystrophy cardiomyopathy.
20 April 2018 (00:00 - 00:00)
Organised by: 

About the speaker

Monzino Cardiology Centre, Milan (Italy)
24 More presentations in this session
Miss K. Perepelina (Saint Petersburg, RU)
Doctor M. Shtatolkina (Tomsk, RU)
Access the full session
The Event
Frontiers in CardioVascular Biology 2018
20 April - 22 April 2018
